Next Article in Journal
Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics
Next Article in Special Issue
Pelvic Actinomycosis Associated with an Intrauterine Contraceptive Device Demonstrated on F-18 FDG PET/CT
Previous Article in Journal
Molecular Imaging of Tumors Using a Quantitative T1 Mapping Technique via Magnetic Resonance Imaging
Previous Article in Special Issue
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
Article Menu

Export Article

Open AccessReview
Diagnostics 2015, 5(3), 333-357; doi:10.3390/diagnostics5030333

PET/MRI in Oncological Imaging: State of the Art

1
Cancer Imaging Department, Division of Imaging Sciences and Biomedical Engineering, King's College London, London, SE1 7EH, UK
2
PET Imaging Centre and the Division of Imaging Sciences and Biomedical Engineering, King's College London, London, SE1 7EH, UK
3
Medical Physics, Guy's & St Thomas' Hospitals NHS Foundation Trust, London, SE1 7EH, UK
4
Department of Radiology, Guy's & St Thomas' Hospitals NHS Foundation Trust, London, SE1 7EH, UK
*
Author to whom correspondence should be addressed.
Academic Editor: Andreas Kjaer
Received: 16 June 2015 / Revised: 9 July 2015 / Accepted: 10 July 2015 / Published: 21 July 2015
(This article belongs to the Collection Hybrid Imaging in Medicine)
View Full-Text   |   Download PDF [4938 KB, uploaded 21 July 2015]   |  

Abstract

Positron emission tomography (PET) combined with magnetic resonance imaging (MRI) is a hybrid technology which has recently gained interest as a potential cancer imaging tool. Compared with CT, MRI is advantageous due to its lack of ionizing radiation, superior soft-tissue contrast resolution, and wider range of acquisition sequences. Several studies have shown PET/MRI to be equivalent to PET/CT in most oncological applications, possibly superior in certain body parts, e.g., head and neck, pelvis, and in certain situations, e.g., cancer recurrence. This review will update the readers on recent advances in PET/MRI technology and review key literature, while highlighting the strengths and weaknesses of PET/MRI in cancer imaging. View Full-Text
Keywords: PET/MRI; MR-PET; cancer; diagnosis; imaging PET/MRI; MR-PET; cancer; diagnosis; imaging
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bashir, U.; Mallia, A.; Stirling, J.; Joemon, J.; MacKewn, J.; Charles-Edwards, G.; Goh, V.; Cook, G.J. PET/MRI in Oncological Imaging: State of the Art. Diagnostics 2015, 5, 333-357.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diagnostics EISSN 2075-4418 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top